Cover Image
市場調查報告書

ntares Pharma, Inc.:產品平台分析

Antares Pharma, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 192476
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
ntares Pharma, Inc.:產品平台分析 Antares Pharma, Inc. - Product Pipeline Review - 2015
出版日期: 2015年05月27日 內容資訊: 英文 29 Pages
簡介

Antares Pharma, Inc.ha是著重於自行注射用醫藥品及凝膠狀產品的特殊化型的製藥企業。

本報告提供Antares Pharma, Inc.的治療藥開發平台現狀及各開發階段比較分析,為您彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Antares Pharma, Inc.的基本資料

Antares Pharma, Inc.概要

  • 主要資訊
  • 企業資料

Antares Pharma, Inc.:R&D概要

  • 主要的治療範圍

Antares Pharma, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

Antares Pharma, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Antares Pharma, Inc.:藥物簡介

  • (nestorone + estradiol)
  • VIBEX QS T
  • VIBEX QS M

Antares Pharma, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Antares Pharma, Inc.:最近的開發平台趨勢

Antares Pharma, Inc.:暫停中的計劃

Antares Pharma, Inc.:企業發表

Antares Pharma, Inc.:總公司和子公司的所地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07141CDB

Summary

Global Markets Direct's, 'Antares Pharma, Inc. - Product Pipeline Review - 2015', provides an overview of the Antares Pharma, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Antares Pharma, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Antares Pharma, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Antares Pharma, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Antares Pharma, Inc.'s pipeline products

Reasons to buy

  • Evaluate Antares Pharma, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Antares Pharma, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Antares Pharma, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Antares Pharma, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Antares Pharma, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Antares Pharma, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Antares Pharma, Inc. Snapshot
    • Antares Pharma, Inc. Overview
    • Key Information
    • Key Facts
  • Antares Pharma, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Antares Pharma, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Antares Pharma, Inc. - Pipeline Products Glance
    • Antares Pharma, Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Antares Pharma, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Antares Pharma, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Antares Pharma, Inc. - Drug Profiles
    • testosterone enanthate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • (nestorone + estradiol)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VIBEX QS M
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Antares Pharma, Inc. - Pipeline Analysis
    • Antares Pharma, Inc. - Pipeline Products by Target
    • Antares Pharma, Inc. - Pipeline Products by Route of Administration
    • Antares Pharma, Inc. - Pipeline Products by Molecule Type
    • Antares Pharma, Inc. - Pipeline Products by Mechanism of Action
  • Antares Pharma, Inc. - Recent Pipeline Updates
  • Antares Pharma, Inc. - Dormant Projects
  • Antares Pharma, Inc. - Company Statement
  • Antares Pharma, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Antares Pharma, Inc., Key Information
  • Antares Pharma, Inc., Key Facts
  • Antares Pharma, Inc. - Pipeline by Indication, 2015
  • Antares Pharma, Inc. - Pipeline by Stage of Development, 2015
  • Antares Pharma, Inc. - Monotherapy Products in Pipeline, 2015
  • Antares Pharma, Inc. - Combination Treatment Modalities in Pipeline, 2015
  • Antares Pharma, Inc. - Phase III, 2015
  • Antares Pharma, Inc. - Phase II, 2015
  • Antares Pharma, Inc. - Preclinical, 2015
  • Antares Pharma, Inc. - Pipeline by Target, 2015
  • Antares Pharma, Inc. - Pipeline by Route of Administration, 2015
  • Antares Pharma, Inc. - Pipeline by Molecule Type, 2015
  • Antares Pharma, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Antares Pharma, Inc. - Recent Pipeline Updates, 2015
  • Antares Pharma, Inc. - Dormant Developmental Projects,2015
  • Antares Pharma, Inc., Other Locations
  • Antares Pharma, Inc., Subsidiaries

List of Figures

  • Antares Pharma, Inc. - Pipeline by Top 10 Indication, 2015
  • Antares Pharma, Inc. - Pipeline by Stage of Development, 2015
  • Antares Pharma, Inc. - Monotherapy Products in Pipeline, 2015
  • Antares Pharma, Inc. - Pipeline by Top 10 Target, 2015
  • Antares Pharma, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Antares Pharma, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Antares Pharma, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top